Byotrol PLC Exercise of Options and Total Voting Rights (9161R)
03 Luglio 2020 - 8:00AM
UK Regulatory
TIDMBYOT
RNS Number : 9161R
Byotrol PLC
03 July 2020
Byotrol plc ("Byotrol" or the "Group")
Exercise of Options and Total Voting Rights
Byotrol plc (AIM:BYOT), the specialist infection prevention and
control technology company, announces that it has allotted a total
of 2,593,975 new ordinary shares of 0.25 pence each in the capital
of the Company ("Ordinary Shares") following the exercise of
options by certain employees, all of whom are below Board
level.
Application has been made to the London Stock Exchange for the
2,593,975 new Ordinary Shares to be admitted to trading on AIM
("Admission") and it is expected that Admission will become
effective and trading will commence at 8.00 a.m. on 8 July
2020.
After Admission, the total number of Ordinary Shares in issue
will be 442,842,280 and the total number of voting rights will
therefore be 442,842,280. This figure may be used by shareholders
as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change to their interest in, the share capital of the Company under
the FCA's Disclosure and Transparency Rules.
Enquiries:
Byotrol plc
David Traynor - Chief Executive Officer
Nic Hellyer - Chief Financial Officer 01925 742 000
finnCap
Geoff Nash/Kate Bannatyne - Corporate Finance 020 7220 0500
Richard Chambers/Manasa Patil - ECM
Flagstaff Strategic and Investor Communications
Tim Thompson/Andrea Seymour/Fergus Mellon 020 7129 1474
byotrol@flagstaffcomms.com
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) No 596/2014.
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection
prevention and control company, operating globally in the
Healthcare, Industrial, Food and Consumer sectors, providing low
toxicity products with a broad-based and targeted efficacy across
all microbial classes; bacteria, viruses (including coronavirus),
fungi, moulds, mycobacteria and algae.
Byotrol's products can be used stand-alone or as ingredients
within existing products, where they can significantly improve
their performance, especially in personal hygiene, domestic and
industrial disinfection, odour control, food production and food
management.
Byotrol develops and commercialises technologies that create
easier, safer and cleaner lives for everyone.
For more information, please go to byotrol.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
IOEFLFLDDTIFIII
(END) Dow Jones Newswires
July 03, 2020 02:00 ET (06:00 GMT)
Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Set 2024 a Ott 2024
Grafico Azioni Byotrol (LSE:BYOT)
Storico
Da Ott 2023 a Ott 2024